Beyond its role in MB, LIN28B has been implicated in several other malignancies, including hepatocellular carcinoma, colorectal cancer, and ovarian cancer, where it contributes to tumour progression, stemness, and resistance to therapy [35,48,49,50,51,52]. This evidence concerns the gene LIN28B and hepatocellular carcinoma.